The U.S. guidewires market size was estimated at USD 830.6 million in 2024 and is projected to reach USD 1.27 billion by 2033, growing at a CAGR of 4.87% from 2025 to 2033. The increasing prevalence of urological disorders, cardiovascular diseases, and Peripheral Artery Disease (PAD) is significantly driving the growth of the market.
Moreover, a growing number of minimally invasive surgeries, paired with a rising geriatric population, presents an opportunity for increased product demand. Factors such as a rising number of coronary & peripheral intervention procedures and an increase in the geriatric population are resulting in high demand for minimally invasive surgeries in the country. This is expected to have a positive impact on the market in the years to come. A majority of people in the U.S. are inclined towards noninvasive surgeries owing to the probability of high infection associated with invasive procedures. According to data published by Yale Medicine, approximately 900,000 percutaneous coronary interventions (PCIs) are performed in the U.S. every year. Thus, such a high procedural volume is anticipated to support the nationwide demand for guidewires.
Moreover, the rising number of clinical trials and research studies aimed at expanding the applications of guidewires is expected to significantly support the country’s market growth. These trials are increasingly focused on assessing the safety and efficacy of guidewires across various procedures, as well as accelerating the development of novel and advanced products. Research institutions, academic centers, and industry players are actively collaborating on these investigations. Favorable clinical outcomes validate product performance, facilitating regulatory approvals, enhancing clinician adoption, and contributing to broader market expansion.
This product will be delivered within 2 business days.
Moreover, a growing number of minimally invasive surgeries, paired with a rising geriatric population, presents an opportunity for increased product demand. Factors such as a rising number of coronary & peripheral intervention procedures and an increase in the geriatric population are resulting in high demand for minimally invasive surgeries in the country. This is expected to have a positive impact on the market in the years to come. A majority of people in the U.S. are inclined towards noninvasive surgeries owing to the probability of high infection associated with invasive procedures. According to data published by Yale Medicine, approximately 900,000 percutaneous coronary interventions (PCIs) are performed in the U.S. every year. Thus, such a high procedural volume is anticipated to support the nationwide demand for guidewires.
Moreover, the rising number of clinical trials and research studies aimed at expanding the applications of guidewires is expected to significantly support the country’s market growth. These trials are increasingly focused on assessing the safety and efficacy of guidewires across various procedures, as well as accelerating the development of novel and advanced products. Research institutions, academic centers, and industry players are actively collaborating on these investigations. Favorable clinical outcomes validate product performance, facilitating regulatory approvals, enhancing clinician adoption, and contributing to broader market expansion.
U.S. Guidewires Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. guidewires market report based on product:Product Outlook (Revenue, USD Million, 2021-2033)
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Guidewires Market Variables, Trends & Scope
Chapter 4. U.S. Guidewires Market: Product Estimates & Trend Analysis
Chapter 5. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The key companies profiled in this U.S. Guidewires market report include:- Boston Scientific Corporation
- Medtronic
- Cook
- Terumo Medical Corporation
- Abbott
- Stryker
- Teleflex Incorporated
- BD
- ASAHI INTECC USA, INC.
- Olympus America
- Dornier MedTech.
- Koninklijke Philips N.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 70 |
| Published | November 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 830.6 Million |
| Forecasted Market Value ( USD | $ 1270 Million |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | United States |
| No. of Companies Mentioned | 13 |
